PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Recognises DiscoveRx with Product Line Strategy Award - U.S-based DiscoveRx is the recipient of the 2008 European Cell-Based Assays Product Line Strategy Award
Frost & Sullivan Recognises DiscoveRx with Product Line Strategy Award

 

NewswireToday - /newswire/ - London, United Kingdom, 2008/09/10 - U.S-based DiscoveRx is the recipient of the 2008 European Cell-Based Assays Product Line Strategy Award.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

DiscoveRx, a leader in G protein-coupled receptors (GPCRs) is recognised for its broad, yet distinctive, portfolio of cell-based assay products that have received outstanding recognition from leading life science organisations.

"DiscoveRx is acknowledged as one of the most active participants in the functional assay market as reflected in the company's continuous efforts in technology innovation such as the PathHunter™ Arrestin technology and the HitHunter™ cAMP Assay; GPCR assay platform, helping to accelerate the discovery of new drug candidates," notes Frost & Sullivan Research Analyst Laleh Safinia. "Having an expanding pipeline of highly promising products, combined with top-quality management and sales, DiscoveRx continues to improve its standing in the functional assay area, influencing the direction of drug discovery."

Founded in 2000, DiscoveRx has pioneered the use of beta-galactosidase enzyme fragment complementation in biochemical and cell-based assays for drug discovery research, holding extensive intellectual property in this area. The company is devoted to the development and commercialisation of functional assays to study GPCRs, kinases and other major drug target classes, with many of their innovative products adopted in pharmaceutical and biotech drug screening laboratories globally.

"To meet the growing demand of functional assays during screening, in 2007, DiscoveRx announced the growing list of GPCRs representing 32 ligand families based on the PathHunter™ Arrestin technology, which measures GPCR activation without the need for target over expression, force coupling, imaging or second messenger detection," remarks Safinia. "With PathHunter™ Flash Detection kit, DiscoveRx also launched a 30 second assay for Beta-Arretin based screening, permitting screens of up to 1,000,000 compounds in 48 hours."

In May 2006, GE Healthcare signed an exclusive distribution agreement for DiscoveRx HitHunter™ cAMP Assays, which are homogeneous cell based assays used to screen for GPCR activation in a microplate based format, designed for high throughput, non-radioactive screening for compounds in drug discovery. Adding the DiscoveRx portfolio has enabled GE Healthcare to offer more comprehensive screening technologies to its customers.

"Such activities further reinforce the fact that DiscoveRx is actively seeking to commercialise and provide early access to new technology platforms in the drug discovery market," states Safinia. "Frost and Sullivan salutes the product line enhancement strategies adopted by the firm and strongly believes that DiscoveRx will continue to enhance its standing in the functional assay area."

The Frost & Sullivan Award for Product Line Strategy is presented each year to a company that has demonstrated the most insight into customer needs and product demands. The recipient company should have optimised its product line by leveraging products with the various price, performance, and feature points required by the market.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About DiscoveRx

Founded in 2000, DiscoveRx (discoverx.com) is a privately held, venture-backed company headquartered in Fremont, California, with an additional office in Birmingham, England. The Company pioneered the use of ß-Galactosidase enzyme fragment complementation in biochemical and cell based assays for discovery research, and holds extensive intellectual property in this area. DiscoveRx is dedicated to the development and commercialization of innovative solutions to study GPCRs, Kinases and other major drug target classes, and many of their innovative products have been widely adopted in pharmaceutical and biotech drug screening laboratories worldwide. For more information regarding this press release and for other collaborative opportunities, please contact Sailaja Kuchibhatla, Sr. Vice President, Business Development.

DiscoveRx Contact:
Sailaja Kuchibhatla – Senior Vice President of Business Development
T: 510.979.1415 x104
E: skuchibhatla@discoverx.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Recognises DiscoveRx with Product Line Strategy Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jasmine Malone – Promotions Coordinator 
+44 207 915 7869 jasmine.malone[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)